Skip to main content
. 2020 Sep 10;64(20):2000108. doi: 10.1002/mnfr.202000108

Figure 2.

Figure 2

Nanoparticle tracking analysis of patient plasma. A) Concentration of all EVs (unstained). B) Concentration of CD62E+ EVs. C) Concentration of CD42a+ EVs.